These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33164940)

  • 1. Risk-Taking Behaviors in Huntington's Disease.
    McDonell KE; Ciriegio AE; Pfalzer AC; Hale L; Shiino S; Riordan H; Moroz S; Darby RR; Compas BE; Claassen DO
    J Huntingtons Dis; 2020; 9(4):359-369. PubMed ID: 33164940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Huntington's Disease: Impulse Control Deficits but Correct Judgment Regarding Risky Situations.
    Galvez V; Fernandez-Ruiz J; Bayliss L; Ochoa-Morales A; Hernandez-Castillo CR; Díaz R; Campos-Romo A
    J Huntingtons Dis; 2017; 6(1):73-78. PubMed ID: 28339399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implicit attitudes towards risky driving behaviors: Evidence of validity for the implicit association test.
    Tosi JD; Ledesma RD; Díaz Lázaro CM; Poó FM
    J Safety Res; 2020 Dec; 75():284-291. PubMed ID: 33334487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep Dysfunction in Huntington's Disease: Perspectives from Patients.
    Tanigaki WK; Rossetti MA; Rocha NP; Stimming EF
    J Huntingtons Dis; 2020; 9(4):345-352. PubMed ID: 32986678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risky, Impulsive, and Self-Destructive Behavior Questionnaire (RISQ): A Validation Study.
    Sadeh N; Baskin-Sommers A
    Assessment; 2017 Dec; 24(8):1080-1094. PubMed ID: 27002123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported impulsivity in Huntington's disease patients and relationship to executive dysfunction and reward responsiveness.
    Johnson PL; Potts GF; Sanchez-Ramos J; Cimino CR
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):694-706. PubMed ID: 27892808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicolegal Aspects of Huntington Disease.
    McDonell KE; Brown BK; Hale L; Darby RR; Stovall J; Compas BE; Claassen DO
    J Am Acad Psychiatry Law; 2021 Dec; 49(4):565-571. PubMed ID: 34341147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-Compulsive Symptoms are Less Common in Huntington's Disease than Reported Earlier.
    Hoffmann R; Schröder N; Brüne M; von Hein S; Saft C
    J Huntingtons Dis; 2019; 8(4):493-500. PubMed ID: 31424414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anosognosia in HD: Comparison of self-report and caregiver ratings with objective performance measures.
    Hughes SB; Churchill E; Smirnova A; Hall A; Culbert B; Snell C; Wright BA; Gilbert PE; Corey-Bloom J
    Parkinsonism Relat Disord; 2023 Feb; 107():105272. PubMed ID: 36610230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the Clinical Utility of DriveSafe DriveAware for People with Huntington's Disease.
    Sondhu MK; Fisher F; Stout JC
    J Huntingtons Dis; 2020; 9(4):353-357. PubMed ID: 33016891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-Compulsive and Perseverative Behaviors in Huntington's Disease.
    Oosterloo M; Craufurd D; Nijsten H; van Duijn E
    J Huntingtons Dis; 2019; 8(1):1-7. PubMed ID: 30714966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risky driving and sexual behaviors as developmental outcomes of co-occurring substance use and antisocial behavior.
    Luk JW; Worley MJ; Winiger E; Trim RS; Hopfer CJ; Hewitt JK; Brown SA; Wall TL
    Drug Alcohol Depend; 2016 Dec; 169():19-25. PubMed ID: 27750183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered driving performance of symptomatic Huntington's disease gene carriers in simulated road conditions.
    Jacobs M; Hart EP; Miranda YM; Groeneveld GJ; van Gerven JMA; Roos RAC
    Traffic Inj Prev; 2018; 19(7):708-714. PubMed ID: 30273496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Negative and Positive Emotion-Dependent Nature of Risky Behaviors Among Substance Dependent Patients.
    Weiss NH; Tull MT; Dixon-Gordon K; Gratz KL
    Assessment; 2018 Sep; 25(6):702-715. PubMed ID: 27581175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk perception and impulsivity: association with risky behaviors and substance abuse disorders.
    Ryb GE; Dischinger PC; Kufera JA; Read KM
    Accid Anal Prev; 2006 May; 38(3):567-73. PubMed ID: 16426559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Caregiver Burden in Huntington's Disease.
    Yu M; Tan K; Koloms K; Bega D
    J Huntingtons Dis; 2019; 8(1):111-114. PubMed ID: 30594932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of a computer-delivered driver safety behavior screening and intervention program initiated during an emergency department visit.
    Murphy M; Smith L; Palma A; Lounsbury D; Bijur P; Chambers P; Gallagher EJ
    Traffic Inj Prev; 2013; 14(1):39-45. PubMed ID: 23259517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.
    Carlozzi NE; Hahn EA; Goodnight SM; Kratz AL; Paulsen JS; Stout JC; Frank S; Miner JA; Cella D; Gershon RC; Schilling SG; Ready RE
    Psychol Assess; 2018 Apr; 30(4):450-458. PubMed ID: 28557480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional latent structure of risk-related phenotypes in healthy young adults.
    Pabon E; MacKillop J; Palmer AA; de Wit H
    Exp Clin Psychopharmacol; 2020 Feb; 28(1):55-64. PubMed ID: 30998058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.